Medical Health Cluster

Artículos destacados

New Data on Heterologous COVID-19 Vaccine Combinations

Switching to a different COVID-19 vaccine after a first dose of the Sputnik V C1, ChAdOx1-S, or BBIBP-CorV vaccines can greatly increase immune response while maintaining safety, according to a study published in Cell Reports Medicine. The results provide information for mixing vaccine types in both primary vaccination and vaccine booster schedules, which […]

Read More

Treatment of Genetic Diseases With CRISPR Genome Editing

In nature, microorganisms use CRISPR (clustered regularly interspaced palindromic repeats) and CRISPR-associated (Cas) proteins for antiviral immunity through recognition and destruction of specific DNA sequences. Over the past decade, CRISPR genome editing has been developed to create transformative technologies to treat, cure, and prevent human disease. How CRISPR Works CRISPR […]

Read More

Public Health Leaders End Weekly Testing Requirements for Workers

SACRAMENTO – To better align state COVID-19 guidance with the most current federal recommendations, the California Department of Public Health (CDPH) is ending COVID-19 policies that required weekly COVID-19 testing for unvaccinated individuals in high-risk workplaces and schools. Health care facilities, other congregate settings and schools will no longer be […]

Read More

WHO: At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; millions may have to live with it for years to come

WHO/Europe urges countries to take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation. New modeling conducted for WHO/Europe by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine in the United States shows that in the first two years of the […]

Read More

Opinión positiva del CHMP de la EMA a las vacunas bivariantes con BA.4 y BA.5 de Pfizer/BioNTech

El Comité de Medicamentos de Uso Humano de la Agencia Europea del Medicamento, CHMP, ha recomendado autorizar una vacuna bivariante adaptada a las subvariantes BA.4 y BA.5, que contiene, además, la cepa ancestral del SARS-CoV-2. El preparado vacunal ha sido elaborado por Pfizer/BioNTech para personas de doce o más años, con […]

Read More

COVID-19 projections: best measured by hospital admissions

IHME produced its latest COVID-19 model run on September 9. Key takeaways: Global infections peaked in August and are currently declining. We expect infections to increase in the Northern Hemisphere in October through the end of 2022, but we do not expect this to lead to major increases in severe disease and […]

Read More

Two Cases of Monkeypox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022

Summary What is already known about this topic? Monkeypox virus (MPXV) typically causes a febrile illness with lymphadenopathy and a diffuse vesiculopustular rash; neurologic complications are rare. The current monkeypox outbreak differs clinically and epidemiologically from previous outbreaks, and little is known about potential associated neurologic complications. What is added by […]

Read More

COVID-19: el resumen semanal (2 al 8 de septiembre de 2022)

Isabel II (1926-2022): una reina entre dos pandemias Isabel II, quien sería monarca británica durante siete décadas, nació en 1926, pocos años después de la pandemia de influenza de 1918-1919 que afectó a un cuarto de los habitantes de Reino Unido e hizo que su población total descendiera en 1919 […]

Read More

Disinfecting Home and Other Non-Healthcare Settings

Purpose of Home Disinfection People with monkeypox who do not require hospitalization may be isolated at home. Monkeypox spreads between people through direct contact with an infectious rash, body fluids, or by respiratory secretions during prolonged, face-to-face contact. Transmission of Monkeypox virus is possible from the onset of the first symptoms until […]

Read More